John G. Saia, Chief Legal Officer of Guardant Health (GH), has demonstrated a consistent pattern of selling activity in the company’s stock over the past year, with no recorded purchases in SEC filings. Since July 2025, Saia has executed multiple sales totaling approximately $2.91 million, with the largest single transaction occurring on January 1, 2026, when he sold shares worth $1.02 million. His most recent sale, on March 15, 2026, amounted to $395,134.78, reinforcing the trend of reducing his position. The transactions include a mix of discretionary sales and those tied to tax obligations or derivative settlements, as indicated by transaction codes "S" and "F" in the filings.
Notably, Saia’s disposals have been concentrated in GH stock, with no activity in other securities. The sales have occurred at regular intervals, including a $865,865 transaction on November 7, 2025, and a $465,552.15 sale on October 1, 2025. Smaller dispositions, such as a $29,312.65 trade on September 15, 2025, suggest a methodical approach rather than a single bulk exit. While the filings do not indicate any acquisitions, the repeated sales—particularly the high-value transactions—highlight a clear divestment trend. The absence of buying activity contrasts with the steady liquidation of holdings, though the reasons for the sales remain undisclosed in the regulatory disclosures.
AI-assisted summary